Aridis Pharmaceuticals, Inc. Annual Earnings Per Share, Basic in USD/shares from 2017 to 2022

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Aridis Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2017 to 2022.
  • Aridis Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2023 was 0 USD/shares.
  • Aridis Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2023 was -0.14 USD/shares, a 92.7% increase year-over-year.
  • Aridis Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -1.62 USD/shares, a 57% increase from 2021.
  • Aridis Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -3.77 USD/shares, a 54.5% decline from 2020.
  • Aridis Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2020 was -2.44 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$2 +$2.15 +57% Jan 1, 2022 Dec 31, 2022 10-K 2023-05-22
2021 -$4 -$1 -54.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-05-22
2020 -$2 Jan 1, 2020 Dec 31, 2020 10-K 2022-04-13
2018 -$7 +$158 +95.5% Jan 1, 2018 Dec 31, 2018 10-K 2019-03-28
2017 -$165 Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.